Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
While it has not received FDA approval for therapeutic use, it is available for research purposes and is used in metabolic optimization protocols
It tracks closely with the metabolic deterioration that characterizes the third and fourth decades of life: rising fasting insulin, expanding visceral adipose tissue, declining mitochondrial density in skeletal muscle, and blunted exercise adaptability
BPC-157 is a peptide produced in the lab with properties identical to naturally occurring body peptides
Cardiovascular diseases aggravate healthcare costs and are a significant economic burden (4)
